Where Does DaVita Stock Rank Among Competitors?
DaVita‘s (DVA) stock has delivered moderate returns over the past year, but how does it truly stack up against peers navigating evolving specialized healthcare demands? A closer look reveals strong profitability and free cash flow generation, steady revenue growth, and a reasonable valuation, but potential upside may be constrained if larger, more diversified providers like HCA and EHC continue to capture market momentum.
- DVA’s 14.7% operating margin, strong yet below EHC (17.3%), reflects dialysis market dominance but faces profit pressure from government reimbursement rates.
- DVA’s 6.5% revenue growth is moderate, outpacing CYH but trailing peers, signaling challenges in dialysis volume amidst evolving care settings.
- DVA’s 4.5% stock gain and 14.2 PE trail peers like HCA/EHC, potentially due to dialysis market regulatory risks and patient volume concerns.
Here’s how DaVita stacks up across size, valuation, and profitability versus key peers.
| DVA | HCA | EHC | SEM | CYH | PRVA | |
|---|---|---|---|---|---|---|
| Market Cap ($ Bil) | 10.6 | 119.3 | 10.8 | 1.8 | 0.5 | 3.1 |
| Revenue ($ Bil) | 13.6 | 75.6 | 5.8 | 5.4 | 12.6 | 2.0 |
| PE Ratio | 14.2 | 17.6 | 19.9 | 16.3 | 1.5 | 168.3 |
| LTM Revenue Growth | 6.5% | 7.1% | 11.1% | 45.3% | 0.7% | 19.0% |
| LTM Operating Margin | 14.7% | 15.8% | 17.3% | 5.5% | 8.6% | 1.4% |
| LTM FCF Margin | 9.6% | 10.2% | 6.9% | 3.2% | 1.1% | 5.4% |
| 12M Market Return | 4.5% | 65.6% | 8.7% | -17.9% | 0.5% | 3.5% |
For more details on DaVita, read Buy or Sell DVA Stock. Below we compare DVA’s growth, margin, and valuation with peers across years
Revenue Growth Comparison
- Beyond Price Action: Does NOW Offer Genuine Diversification?
- Is Las Vegas Sands Stock Poised for a Rally?
- 4 Catalysts to Monitor Over In The Next 2 Quarters For AAPL Stock
- Truist Financial Earnings Show Strong EPS Jump
- Could Qualys Stock’s Cash Flow Spark the Next Rally?
- Abbott Laboratories Stock Hands $28 Bil Back – Worth a Look?
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| DVA | 6.5% | 6.5% | 5.6% | 4.6% | |
| HCA | 7.1% | 7.1% | 8.7% | 7.9% | |
| EHC | 11.1% | – | 11.9% | 10.4% | 8.3% |
| SEM | 45.3% | – | 7.5% | 4.7% | -25.7% |
| CYH | 0.7% | – | 1.2% | 2.3% | -1.3% |
| PRVA | 19.0% | – | 4.7% | 22.2% | 40.4% |
Operating Margin Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| DVA | 14.7% | 14.7% | 15.3% | 13.2% | |
| HCA | 15.8% | 15.8% | 14.9% | 14.8% | |
| EHC | 17.3% | – | 16.1% | 15.2% | 14.5% |
| SEM | 5.5% | – | 5.2% | 5.5% | 3.1% |
| CYH | 8.6% | – | 6.7% | 7.0% | 5.9% |
| PRVA | 1.4% | – | 1.0% | 1.2% | -1.4% |
PE Ratio Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| DVA | 14.2 | 11.3 | 13.6 | 13.8 | |
| HCA | 17.6 | 16.3 | 13.5 | 14.1 | |
| EHC | 19.9 | – | 23.3 | 26.1 | 24.4 |
| SEM | 16.3 | – | 8.6 | 9.5 | 18.4 |
| CYH | 1.5 | – | -0.8 | -2.9 | 8.8 |
| PRVA | 168.3 | – | 196.8 | 98.9 | -296.9 |
Still not sure about DVA stock? Consider portfolio approach.
Portfolios Over Individual Stock Picks
Single stocks swing wildly but staying invested matters. A well built portfolio helps you stay invested, captures upside and softens the blows from individual stocks.
Beating the market consistently is hard, but the Trefis High Quality (HQ) Portfolio makes it look achievable. By selecting 30 high-conviction stocks, the HQ strategy has historically outpaced the S&P 500, S&P Mid-cap, and Russell 2000. See how this curated selection delivers superior risk-adjusted returns in our detailed performance factsheet.